[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fW1oECybhSGPsEA-ebpPpu4nU07rMTqBts1rUkKuEiqo":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":52,"rows":59},"Laureate Institute for Brain Research, Inc.",[4],53,false,14,2,5529,4,42,[14,17,20,23,26,29,31,34],{"name":15,"count":16},"Depression",11,{"name":18,"count":19},"Major Depressive Disorder",9,{"name":21,"count":22},"Anxiety",7,{"name":24,"count":25},"Anorexia Nervosa",6,{"name":27,"count":28},"Generalized Anxiety Disorder",5,{"name":30,"count":11},"Panic Disorder",{"name":32,"count":33},"Agoraphobia",3,{"name":35,"count":33},"Social Anxiety Disorder",[37,42,47],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT04751331","Neural Response to Inflammatory Challenge in Major Depressive Disorder","2026-04","LPS",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT06088732","Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression","2026-12-31","Ibuprofen 800 mg",{"nctId":48,"briefTitle":49,"date":50,"intervention":51},"NCT06004115","Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression","2027-12-31","Lorazepam",[53,54,55,56,57,58],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[60,88,110,128,149,177,195,219,245,263,286,310,347,365],{"intervention":51,"totalTrials":61,"cells":62},1,{"EARLY_PHASE1":63,"PHASE1":66,"PHASE2":68,"PHASE3":70,"PHASE4":72,"NA":86},{"trials":64,"activeCount":65},[],0,{"trials":67,"activeCount":65},[],{"trials":69,"activeCount":65},[],{"trials":71,"activeCount":65},[],{"trials":73,"activeCount":61,"soonestReadout":50},[74],{"nctId":48,"briefTitle":49,"status":75,"phases":76,"primaryCompletion":50,"completion":50,"start":77,"enrollment":78,"conditions":79,"interventions":85},"RECRUITING",[57],"2023-11-08",165,[80,81,15,82,83,84],"Depression, Anxiety","Fear","Anxiety and Fear","Anxiety Disorders","Anxious Depression",[51],{"trials":87,"activeCount":65},[],{"intervention":41,"totalTrials":61,"cells":89},{"EARLY_PHASE1":90,"PHASE1":92,"PHASE2":94,"PHASE3":104,"PHASE4":106,"NA":108},{"trials":91,"activeCount":65},[],{"trials":93,"activeCount":65},[],{"trials":95,"activeCount":61,"soonestReadout":40},[96],{"nctId":38,"briefTitle":39,"status":75,"phases":97,"primaryCompletion":40,"completion":98,"start":99,"enrollment":100,"conditions":101,"interventions":102},[54,55],"2026-12","2021-05-15",180,[18],[41,103],"Saline",{"trials":105,"activeCount":65},[],{"trials":107,"activeCount":65},[],{"trials":109,"activeCount":65},[],{"intervention":103,"totalTrials":61,"cells":111},{"EARLY_PHASE1":112,"PHASE1":114,"PHASE2":116,"PHASE3":122,"PHASE4":124,"NA":126},{"trials":113,"activeCount":65},[],{"trials":115,"activeCount":65},[],{"trials":117,"activeCount":61,"soonestReadout":40},[118],{"nctId":38,"briefTitle":39,"status":75,"phases":119,"primaryCompletion":40,"completion":98,"start":99,"enrollment":100,"conditions":120,"interventions":121},[54,55],[18],[41,103],{"trials":123,"activeCount":65},[],{"trials":125,"activeCount":65},[],{"trials":127,"activeCount":65},[],{"intervention":46,"totalTrials":61,"cells":129},{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":134,"PHASE3":143,"PHASE4":145,"NA":147},{"trials":131,"activeCount":65},[],{"trials":133,"activeCount":65},[],{"trials":135,"activeCount":61,"soonestReadout":45},[136],{"nctId":43,"briefTitle":44,"status":75,"phases":137,"primaryCompletion":45,"completion":45,"start":138,"enrollment":139,"conditions":140,"interventions":142},[54,55],"2024-03-12",20,[141],"Bipolar Depression",[46],{"trials":144,"activeCount":65},[],{"trials":146,"activeCount":65},[],{"trials":148,"activeCount":65},[],{"intervention":150,"totalTrials":61,"cells":151},"Minocycline",{"EARLY_PHASE1":152,"PHASE1":154,"PHASE2":156,"PHASE3":158,"PHASE4":173,"NA":175},{"trials":153,"activeCount":65},[],{"trials":155,"activeCount":65},[],{"trials":157,"activeCount":65},[],{"trials":159,"activeCount":65},[160],{"nctId":161,"briefTitle":162,"status":163,"phases":164,"primaryCompletion":165,"completion":166,"start":167,"enrollment":168,"conditions":169,"interventions":171},"NCT01429272","Minocycline and Aspirin in the Treatment of Bipolar Depression","COMPLETED",[56],"2015-08","2015-09","2011-09",99,[170],"Bipolar Disorder Depression",[150,172],"Aspirin",{"trials":174,"activeCount":65},[],{"trials":176,"activeCount":65},[],{"intervention":172,"totalTrials":61,"cells":178},{"EARLY_PHASE1":179,"PHASE1":181,"PHASE2":183,"PHASE3":185,"PHASE4":191,"NA":193},{"trials":180,"activeCount":65},[],{"trials":182,"activeCount":65},[],{"trials":184,"activeCount":65},[],{"trials":186,"activeCount":65},[187],{"nctId":161,"briefTitle":162,"status":163,"phases":188,"primaryCompletion":165,"completion":166,"start":167,"enrollment":168,"conditions":189,"interventions":190},[56],[170],[150,172],{"trials":192,"activeCount":65},[],{"trials":194,"activeCount":65},[],{"intervention":196,"totalTrials":61,"cells":197},"Ibuprofen",{"EARLY_PHASE1":198,"PHASE1":200,"PHASE2":202,"PHASE3":204,"PHASE4":215,"NA":217},{"trials":199,"activeCount":65},[],{"trials":201,"activeCount":65},[],{"trials":203,"activeCount":65},[],{"trials":205,"activeCount":65},[206],{"nctId":207,"briefTitle":208,"status":163,"phases":209,"primaryCompletion":210,"completion":210,"start":211,"enrollment":212,"conditions":213,"interventions":214},"NCT02507219","Study of Ibuprofen Effects on Brain Function",[55,56],"2015-10","2015-07",24,[18],[196],{"trials":216,"activeCount":65},[],{"trials":218,"activeCount":65},[],{"intervention":220,"totalTrials":61,"cells":221},"Escitalopram + RT2CK17",{"EARLY_PHASE1":222,"PHASE1":224,"PHASE2":226,"PHASE3":239,"PHASE4":241,"NA":243},{"trials":223,"activeCount":65},[],{"trials":225,"activeCount":65},[],{"trials":227,"activeCount":65},[228],{"nctId":229,"briefTitle":230,"status":231,"phases":232,"primaryCompletion":233,"completion":233,"start":234,"enrollment":235,"conditions":236,"interventions":237},"NCT03388164","Adherence to Antidepressant Treatment in Subjects With Depression","TERMINATED",[55],"2019-05-15","2018-01-01",23,[15],[220,238],"Escitalopram + Placebo",{"trials":240,"activeCount":65},[],{"trials":242,"activeCount":65},[],{"trials":244,"activeCount":65},[],{"intervention":238,"totalTrials":61,"cells":246},{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":257,"PHASE4":259,"NA":261},{"trials":248,"activeCount":65},[],{"trials":250,"activeCount":65},[],{"trials":252,"activeCount":65},[253],{"nctId":229,"briefTitle":230,"status":231,"phases":254,"primaryCompletion":233,"completion":233,"start":234,"enrollment":235,"conditions":255,"interventions":256},[55],[15],[220,238],{"trials":258,"activeCount":65},[],{"trials":260,"activeCount":65},[],{"trials":262,"activeCount":65},[],{"intervention":264,"totalTrials":61,"cells":265},"Valganciclovir",{"EARLY_PHASE1":266,"PHASE1":268,"PHASE2":270,"PHASE3":280,"PHASE4":282,"NA":284},{"trials":267,"activeCount":65},[],{"trials":269,"activeCount":65},[],{"trials":271,"activeCount":65},[272],{"nctId":273,"briefTitle":274,"status":163,"phases":275,"primaryCompletion":276,"completion":276,"start":277,"enrollment":139,"conditions":278,"interventions":279},"NCT04724447","ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION",[54,55],"2026-04-01","2021-11-23",[18],[264],{"trials":281,"activeCount":65},[],{"trials":283,"activeCount":65},[],{"trials":285,"activeCount":65},[],{"intervention":287,"totalTrials":61,"cells":288},"Lipopolysaccharide",{"EARLY_PHASE1":289,"PHASE1":291,"PHASE2":302,"PHASE3":304,"PHASE4":306,"NA":308},{"trials":290,"activeCount":65},[],{"trials":292,"activeCount":65},[293],{"nctId":294,"briefTitle":295,"status":163,"phases":296,"primaryCompletion":297,"completion":297,"start":298,"enrollment":299,"conditions":300,"interventions":301},"NCT03142919","Lipopolysaccharide (LPS) Challenge in Depression",[54],"2020-12-01","2017-09-07",64,[18],[287],{"trials":303,"activeCount":65},[],{"trials":305,"activeCount":65},[],{"trials":307,"activeCount":65},[],{"trials":309,"activeCount":65},[],{"intervention":311,"totalTrials":9,"cells":312},"Isoproterenol",{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":321,"NA":323},{"trials":314,"activeCount":65},[],{"trials":316,"activeCount":65},[],{"trials":318,"activeCount":65},[],{"trials":320,"activeCount":65},[],{"trials":322,"activeCount":65},[],{"trials":324,"activeCount":65},[325,336],{"nctId":326,"briefTitle":327,"status":163,"phases":328,"primaryCompletion":329,"completion":329,"start":330,"enrollment":331,"conditions":332,"interventions":334},"NCT02615119","Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa",[58],"2023-06","2015-10-01",97,[24,18,27,30,333],"Brain Injury",[311,335],"Normal saline",{"nctId":337,"briefTitle":338,"status":339,"phases":340,"primaryCompletion":341,"completion":342,"start":343,"enrollment":344,"conditions":345,"interventions":346},"NCT03019081","Augmented Interoceptive Exposure Training in Anorexia Nervosa","UNKNOWN",[58],"2021-08","2024-11","2017-01",25,[24],[311],{"intervention":335,"totalTrials":61,"cells":348},{"EARLY_PHASE1":349,"PHASE1":351,"PHASE2":353,"PHASE3":355,"PHASE4":357,"NA":359},{"trials":350,"activeCount":65},[],{"trials":352,"activeCount":65},[],{"trials":354,"activeCount":65},[],{"trials":356,"activeCount":65},[],{"trials":358,"activeCount":65},[],{"trials":360,"activeCount":65},[361],{"nctId":326,"briefTitle":327,"status":163,"phases":362,"primaryCompletion":329,"completion":329,"start":330,"enrollment":331,"conditions":363,"interventions":364},[58],[24,18,27,30,333],[311,335],{"intervention":366,"totalTrials":61,"cells":367},"INFLUENZA VACCINE",{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":378},{"trials":369,"activeCount":65},[],{"trials":371,"activeCount":65},[],{"trials":373,"activeCount":65},[],{"trials":375,"activeCount":65},[],{"trials":377,"activeCount":65},[],{"trials":379,"activeCount":65},[380],{"nctId":381,"briefTitle":382,"status":231,"phases":383,"primaryCompletion":384,"completion":384,"start":211,"enrollment":25,"conditions":385,"interventions":387},"NCT02415166","Influenza Challenge in Mood Disorders",[58],"2016-03",[386],"MAJOR DEPRESSIVE DISORDER",[366]]